Inhibition of non-homologous end joining repair impairs pancreatic cancer growth and enhances radiation response.
Pancreatic ductal adenocarcinoma (PDAC) is amongst the deadliest of human cancers, due to its late diagnosis as well as its intense resistance to currently available therapeutics. To identify mechanisms as to why PDAC are refractory to DNA damaging cytoxic chemotherapy and radiation, we performed a...
Main Authors: | Ying-Hua Li, Xiaoxu Wang, Yunfeng Pan, Dong-Hyun Lee, Dipanjan Chowdhury, Alec C Kimmelman |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3377637?pdf=render |
Similar Items
-
Apalutamide Sensitizes Prostate Cancer to Ionizing Radiation via Inhibition of Non-Homologous End-Joining DNA Repair
by: Wenhao Zhang, et al.
Published: (2019-10-01) -
Involvement of Caveolin-1 in repair of DNA damage through both homologous recombination and non-homologous end joining.
by: Hua Zhu, et al.
Published: (2010-08-01) -
Making ends meet: repairing breaks in bacterial DNA by non-homologous end-joining.
by: Richard Bowater, et al.
Published: (2006-02-01) -
Making ends meet: repairing breaks in bacterial DNA by non-homologous end-joining.
Published: (2006-02-01) -
Modeling damage complexity-dependent non-homologous end-joining repair pathway
by: Li, Y, et al.
Published: (2014)